Genetic polymorphism and variability of chemical carcinogenesis

Biochemistry (Moscow)

Volumn 73, Issue 5, 2008, Pages 543-554

  Belitsky, G A ^a   Yakubovskaya, M G ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Apoptosis; Chemical carcinogenesis; Cytochrome P450; DNA repair; Gene polymorphism; Initiation; Promotion

Indexed keywords

CELL DEATH; DETOXIFICATION; DNA; GENETIC ENGINEERING; POLYMORPHISM; RISK ASSESSMENT;

CHEMICAL CARCINOGENESIS; CYTOCHROME P450; DNA REPAIR; GENE POLYMORPHISM; INITIATION; PROMOTION;

CARCINOGENS;

CARCINOGEN; CYTOCHROME P450; MUTAGENIC AGENT; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ANIMAL; APOPTOSIS; CELL TRANSFORMATION; CHEMISTRY; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; REVIEW;

ANIMALS; APOPTOSIS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 ENZYME SYSTEM; DNA REPAIR ENZYMES; HUMANS; MUTAGENS; POLYMORPHISM, GENETIC;

EID: 44649172181     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297908050076     Document Type: Review

References (55)

1. Turusov, V. S., Belitsky, G. A., Pylev, L. N., and Koblyakov, V. A. (2004) in Carcinogenesis [in Russian], Meditsina, Moscow, pp. 204-224.
2. Nebert, D. W., and Dalton, T. P. (2006) Nature, 6, 947-960.
3. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004) J. Biol. Chem., 279, 23847-23850.
4. Nelson, D. R. (1999) Arch. Biochem. Biophys., 369, 1-10.
5. Smart, J., and Daly, A. K. (2000) Pharmacogenetics, 10, 1124.
6. McMillan, B. J., and Bradfield, C. F. (2007) Proc. Natl. Acad. Sci. USA, 104, 1412-1417.
7. Sagredo, C., Ovrebo, S., Haugen, A., Fujii-Kuriyama, Y., Baera, R., Botnen, I. V., and Mollerup, S. (2006) Toxicol. Lett., 167, 173-182.
8. Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., and Dalton, T. P. (2000) Biochem. Pharmacol., 59, 65-85.
9. Uno, S. (2004) Mol. Pharmacol., 65, 1225-1237.
10. Conney, A. H., Chang, R. L., Jerina, D. M., and Wei, S. (1994) Drug Metab. Rev., 26, 125-163.
11. Gillis, B., Gavin, I. M., Arbieva, Z., King, S. T., Jayaraman, S., and Prabhakar, B. S. (2007) Genomics, 90, 324-333.
12. Hishida, A. (2005) Asian Pac. J. Cancer Prev., 6, 251-255.
13. Flowers, L., Ohnishi, S. T., and Penning, T. M. (1997) Biochemistry, 36, 8640-8648.
14. McLure, K. G., and Kastan, M. B. (2005) in 25 Years of p53 Research (Hainaut, P., and Wiman, K. G., eds.) Springer, Dordrecht, pp. 53-73.
15. Roos, W. P., and Kaina, B. (2006) TRENDS Mol. Med., 12, 440-450.
16. Bond, G. L., Hu, W., and Levine, A. A. (2005) Cancer Res., 65, 5481-5484.
17. Soussi, T. (2005) in 25 Years of p53 Research (Hainaut, P., and Wiman, K. G., eds.) Springer, Dordrecht, pp. 255-292.
18. Shen, H., Spitz, M. R., Qiao, Y., Zheng, Y., Hong, W. K., and Wei, Q. (2002) Lung Cancer, 36, 243-247.
19. Soifer, V. N. (1997) Soros Obrazovat. Zh., 8, 4-13.
20. Deutsch, W. A., and Linn, S. (1979) Proc. Natl. Acad. Sci. USA, 76, 141-144.
21. Tsutsumi, S., Takeshita, H., Yasuda, T., Kuwano, H., and Kishi, K. (2000) Cancer Lett., 16, 109-112.
22. Tranah, G. J., Bugni, J., Giovannucci, E., Ma, J., Fuchs, C., Hines, L., Samson, L., and Hunter, D. J. (2006) Cancer Causes Control., 17, 721-731.
23. Chen, L., Elahi, A., Pow-Sang, J., Lazarus, P., and Park, J. (2003) J. Urol., 170, 2471-2474.
24. Sobol, R. W., Horton, J. K., Kuhn, R., Gu, H., Singhal, R. K., Prasad, R., Rajewsky, K., and Wilson, S. H. (1996) Nature, 379, 183-186.
25. Ochs, K., Sobol, R. W., Wilson, S. H., and Kaina, B. (1999) Cancer Res., 59, 1544-1551.
26. Li, C., Hu, Z., Liu, Z., Wang, L. E., and Strom, S. S. (2006) Cancer Epidemiol. Biomarkers Prev., 15, 2526-2532.
27. IARC (1994) IARC Scientific Publication No. 125, Lyon.
28. Figueroa, J. D., Malats, N., Rothman, N., Real, F. X., and Silverman, D. (2007) Carcinogenesis, 28, 1788-1793.
29. Berenblum, I., and Shubik, P. (1949) Br. J. Cancer, 3, 384-386.
30. Skulachev, V. P. (2006) Apoptosis, 11, 473-485.
31. Archakov, A., and Zhukov, A. (1989) in Frontiers in Biotransformation (Ruckpaul, K., and Kein, H., eds.) Berlin, pp. 151-175.
32. Kopnin, P. B., Agapova, L. S., Kopnin, B. P., and Chumakov, P. M. (2007) Cancer Res., 67, 4671-4678.
33. Espinosa, C. E. S., and Slack, F. J. (2006) J. Biol. Med., 79, 131-140.
34. Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., and Shimizu, M. (2005) Proc. Natl. Acad. Sci. USA, 102, 13944-13949.
35. Li, A. G., Lu, S. L., Han, G., Hoot, K. E., and Wang, X. J. (2006) Mol. Carcinog., 45, 389-396.
36. Wagenlehner, F. M., Elkahwaji, J. E., Algaba, F., Bjerklund-Johansen, T., Naber, K. G., Hartung, R., and Weidner, W. (2007) BJU Int., 100, 733-737.
37. Park, K. T., Mitchell, K. A., Huang, G., and Elferink, C. J. (2005) Mol. Pharmacol., 67, 612-622.
38. Puga, A., Barnes, S. J., Dalton, T. P., Knudsen, E. S., and Maier, M. A. (2000) J. Biol. Chem., 275, 2943-2950.
39. Ohtake, F. (2003) Nature, 423, 545-550.
40. Mortensen, A. S., and Arukwe, A. (2007) Comp. Hepatol., 6, 2-5.
41. Ichihara, S., Yamada, Y., Ichihara, G., Nakajima, T., Li, P., Kondo, T., Gonzalez, F. J., and Murohara, T. (2007) Arterioscler. Thromb. Vasc. Biol., 27, 1297-1304.
42. Kim, I., Morimura, K., Shah, Y., Yang, O., Ward, J. M., and Gonzalez, F. J. (2007) Carcinogenesis, 28, 940-946.
43. Chuu, C. P., Kokontis, J. M., Hiipakka, R. A., and Liao, S. (2007) J. Biomed. Sci., 14, 543-553.
44. Zelcer, N., and Tontonoz, P. (2006) J. Clin. Invest., 116, 607-614.
45. Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., and Hetzel, M. R. (1984) Nature, 312, 169-170.
46. Griffin, M. D., Dong, X., and Kumar, R. (2007) Arch. Biochem. Biophys., 460, 218-226.
47. Caporaso, N., Hayes, R. B., Dosemeci, M., Hoover, R., Ayesh, R., Hetzel, M., and Idle, J. (1989) Cancer Res., 49, 3675-3679.
48. Yang, M., Choi, Y., Hwangbo, B., and Lee, J. S. (2007) Lung Cancer, 57, 135-142.
49. Vineis, P., Anttila, S., Benhamou, S., and Spinola, M. (2007) Carcinogenesis, 28, 1902-1905.
50. Wei, Q., Cheng, L., Amos, C. I., Wang, L. E., Guo, Z., Hong, W. K., and Spitz, M. R. (2000) J. Natl. Cancer Inst., 92, 1764-1772.
51. Zienolddiny, S., Campa, D., Lind, H., Ryberg, D., Skaug, V., Stangeland, L., Phillips, D. H., Canzian, F., and Haugen, A. (2006) Carcinogenesis, 27, 560-567.
52. Hung, R. J., Brennan, P., Canzian, F., Szeszenia-Dabrowska, N., Zaridze, D., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Foretova, L., Janout, K., Bencko, H., Chabrier, A., Borel, S., Hall, J., and Boffetta, P. (2005) J. Natl. Cancer Inst., 97, 567-576.
53. Hu, Z. B., Zhu, J. F., Huo, X., Qian, J., Wei, Q. Y., and Shen, H. B. (2005) Pharmacogenet. Genomics, 15, 457-463.
54. Hao, B., Miao, X., Li, Y., Zhang, X., Sun, T., Liang, G., Zhao, Y., Zhou, Y., Wang, H., Chen, X., Zhang, L., Tan, W., Wei, Q., Lin, D., and He, F. (2006) Oncogene, 25, 3613-3620.
55. Kiyohara, C., and Yoshimasu, K. (2007) Int. J. Med. Sci., 4, 59-71.